This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ASM journals
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levin, T. P.
Right arrow Articles by Fekete, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levin, T. P.
Right arrow Articles by Fekete, T.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, March 2005, p. 1222-1224, Vol. 49, No. 3
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.3.1222-1224.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Potential Clindamycin Resistance in Clindamycin-Susceptible, Erythromycin-Resistant Staphylococcus aureus: Report of a Clinical Failure

Todd P. Levin,1* Byungse Suh,1 Peter Axelrod,1 Allan L. Truant,1 and Thomas Fekete1

Temple University School of Medicine, Philadelphia, Pennsylvania1

Received 25 June 2004/ Returned for modification 3 October 2004/ Accepted 4 November 2004

The erm gene product confers clindamycin resistance on Staphylococcus aureus. We report a clindamycin clinical failure where resistance developed on therapy in a D-test-positive strain. D tests of 91 clindamycin-susceptible, erythromycin-resistant S. aureus isolates showed that 68% of methicillin-susceptible and 12.3% of methicillin-resistant S. aureus strains were D-test positive.

* Corresponding author. Mailing address: Temple University Hospital, Section of Infectious Diseases, 3401 North Broad St., Philadelphia, PA 19140. Phone: (215) 707-3807. Fax: (215) 707-4414. E-mail: TLevin9696{at}yahoo.com.

Antimicrobial Agents and Chemotherapy, March 2005, p. 1222-1224, Vol. 49, No. 3
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.3.1222-1224.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Moellering, R. C. Jr (2008). A 39-Year-Old Man With a Skin Infection. JAMA 299: 79-87 [Abstract] [Full Text]  
  • Saha, B., Singh, A. K., Ghosh, A., Bal, M. (2008). Identification and characterization of a vancomycin-resistant Staphylococcus aureus isolated from Kolkata (South Asia). J Med Microbiol 57: 72-79 [Abstract] [Full Text]  
  • Fernandes, C. J., O'Sullivan, M. V. N., Cai, Y., Kong, F., Zeng, X., Gilbert, G. L., Kotsiou, G. (2007). Agar Dilution Method for Detection of Inducible Clindamycin Resistance in Staphylococcus spp.. J. Clin. Microbiol. 45: 4018-4020 [Abstract] [Full Text]  
  • Schmitt-Van de Leemput, E., Zadoks, R. N. (2007). Genotypic and Phenotypic Detection of Macrolide and Lincosamide Resistance in Streptococcus uberis. J DAIRY SCI 90: 5089-5096 [Abstract] [Full Text]  
  • Depardieu, F., Podglajen, I., Leclercq, R., Collatz, E., Courvalin, P. (2007). Modes and Modulations of Antibiotic Resistance Gene Expression. Clin. Microbiol. Rev. 20: 79-114 [Abstract] [Full Text]  
  • Luthje, P., Schwarz, S. (2007). Molecular analysis of constitutively expressed erm(C) genes selected in vitro in the presence of the non-inducers pirlimycin, spiramycin and tylosin. J Antimicrob Chemother 59: 97-101 [Abstract] [Full Text]  
  • O'Sullivan, M. V. N., Cai, Y., Kong, F., Zeng, X., Gilbert, G. L. (2006). Influence of Disk Separation Distance on Accuracy of the Disk Approximation Test for Detection of Inducible Clindamycin Resistance in Staphylococcus spp.. J. Clin. Microbiol. 44: 4072-4076 [Abstract] [Full Text]  
  • Huang, H., Flynn, N. M., King, J. H., Monchaud, C., Morita, M., Cohen, S. H. (2006). Comparisons of Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) and Hospital-Associated MSRA Infections in Sacramento, California. J. Clin. Microbiol. 44: 2423-2427 [Abstract] [Full Text]  
  • Patel, M., Waites, K. B., Moser, S. A., Cloud, G. A., Hoesley, C. J. (2006). Prevalence of Inducible Clindamycin Resistance among Community- and Hospital-Associated Staphylococcus aureus Isolates. J. Clin. Microbiol. 44: 2481-2484 [Abstract] [Full Text]  
  • Gemmell, C. G., Edwards, D. I., Fraise, A. P., Gould, F. K., Ridgway, G. L., Warren, R. E., on behalf of the Joint Working Party of the Britis, (2006). Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. J Antimicrob Chemother 57: 589-608 [Abstract] [Full Text]  


Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»